Clinical Trial: Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004010) titled 'Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) for the Treatment of Flank Fat' on May 27.

Brief Summary: Flank region fat is a factor affecting beauty that makes people feel uncomfortable about themselves. In 2015, deoxycholic acid was approved by the American FDA for treatment of flank fat. The purpose of this study is to evaluate the efficacy and safety of deoxycholic acid injection with the brand name Embella(R), manufactured by Espad Pharmed Company, for treatment of this condition.

The Primary objective of this study was the proportion of participants with grade 1 or higher ("imp...